Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL35AP8 is a gene classified as a pseudogene related to ribosomal protein L35a; it does not encode a functional protein and is not involved in cellular protein synthesis or therapeutic targeting. Pseudogenes like RPL35AP8 are considered genomic DNA sequences similar to a known gene but typically lack biological activity due to disabling mutations or lack of expression. There are no known biological functions, disease associations, drug interactions, or biomarker roles for RPL35AP8. It is often included in genome annotations for completeness and as a comparative marker for the study of gene evolution and processing, but it should not be confused with the functional ribosomal protein L35a gene (RPL35A), which is involved in ribosome assembly and function. If structured information is required for an actual ribosomal protein therapeutic target in disease (for example, Diamond-Blackfan anemia), the correct entry would be Ribosomal protein L35a (RPL35A) and not RPL35AP8.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35a pseudogene 8 (RPL35AP8).